Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss

Novo Nordisk, the Danish pharma giant, has seen its fortunes reach astronomical heights since its drugs, Ozempic and Wegovy, took off. Its shares have risen 432% in the last five years, and the company’s market cap far exceeds the size of…





